View in EDS HTML Full Text PDF Full Text

Initial Low-Dose Dacomitinib for First-Line Treatment of Patients With EGFR Exon 21-Mutated Non-Small-Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Initial Low-Dose Dacomitinib for First-Line Treatment of Patients With EGFR Exon 21-Mutated Non-Small-Cell Lung Cancer.
Authors: Liu, Ke-Jun1 (AUTHOR), Huang, Lin-Xuan2 (AUTHOR), Jiang, Guan-Ming1 (AUTHOR), Guo, Ning-Ning3 (AUTHOR), Tan, Qing-Lin1 (AUTHOR), Cai, Yan-Min1 (AUTHOR), Chen, Shi-Yuan1 (AUTHOR), Du, Wei4 (AUTHOR) duwei1227@sina.com, Fang, Nian-Xin5 (AUTHOR) 24588883@qq.com, Jia, Jun1 (AUTHOR) jiwen6465@126.com
Source: Clinical Medicine Insights: Oncology. 5/27/2026, Vol. 20, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11795549
DOI:10.1177/11795549261454548